Funding Rounds
ImmunOs Therapeutics

ImmunOs Therapeutics Series C Round, September 2024

ImmunOs Therapeutics

Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $11.00M

Raised Date: 2024-09-18

Investors